New Brunswick


EXCLUSIVE: Interview with Greg Engel, CEO of Organigram

Organigram Holdings Inc. has appointed a medical marijuana, pharmaceutical, and biotechnology industry veteran as its new chief executive officer, Greg Engel. 420 Intel got a chance to sit down and talk to him in an exclusive interview.

Thank you for taking the time for this interview Greg. So you’re a month in as CEO of Organigram, how’s it going so far?

I’m having a lot of fun. It’s been great – coming from the Canadian cannabis industry is a big advantage. Plus I’ve already worked with Organigram on a number of initiatives together before this position.


New Brunswick Sees Marijuana as 'Green Gold' for Struggling Economy

New Brunswick wants to be your marijuana supplier.

The Liberal government, led by 34-year-old Brian Gallant, sees weed as green gold -- an important creator of revenue and jobs in a province that badly needs both.

It is giving producers financial incentives, has developed a community college program for cannabis technicians, and announced March 24 that marijuana is to be a pillar of its economic strategy.

Marijuana ended the career of a New Brunswick premier in the 1980s, but as Canada nears legalized weed it is taboo no more.

"The New Brunswick government is ... perhaps the most supportive provincial government in the country of the cannabis industry," said Kent Hovey-Smith, a spokesman for Tidal Health Solutions.


Help wanted: marijuana company hiring in St. Stephen, New Brunswick

Canada's Chocolate Town starts manufacturing legal weed? Sounds like the pilot for a sitcom — or a match made in marketing heaven.

Tidal Health Solutions, a medical marijuana company based in St. Stephen, tells CBC News that in addition to current openings for an assistant grower and lab technician, the company also plans to hire "between 30 and 40 workers" in the coming months, according to partner and spokesperson Kent Hovey-Smith.


Greg Engel Appointed OrganiGram CEO, Denis Arsenault Steps up as Executive Chairman

Organigram Holdings Inc. (TSX VENTURE:OGI) (OTCQB:OGRMF) (the "Company") has appointed a medical marijuana, pharmaceutical, and biotechnology industry veteran as its new chief executive officer.

Greg Engel will assume his new role effective March 13, 2017. Mr. Engel succeeds Organigram's current CEO Denis Arsenault who is stepping up to the newly created executive chairman's position. Engel will also join the Board of Directors of Organigram, replacing Larry Rogers, who steps down from the Board, but remains an important part of the Senior Management team.


Organigram Remains A Top Cannabis Pick

Organigram Holdings Inc (CVE:OGI) (OTCMKTS:OGRMF) has held up nicely in spite of a a product recall and profit taking in the cannabis sector. The product recall was initially bad news for the company, but the company handled it in the same way that Johnson & Johnson handled the Tylenol recall in the 1980s. Organigram’s aggressive response strengthened the company’s brand in the eyes of its customers and this bodes well for shareholders. Taking a closer look, it’s easy to see why Organigram remains a top cannabis pick for 2017 and beyond.


[SPONSORED CONTENT] Organigram Supports Health Canada Auditing Improvements

Organigram has enhanced its testing protocol beyond the required regulatory testing to ensure that all products currently being sold on its store, and all products sold in the future, will be tested for an expanded quantity of possible contaminants, including Bifenazate and Myclobutanil. Since the recall dates, Organigram has grown, harvested and tested numerous lots of medical marijuana, and all have passed the additional testing protocols.

"We completely support Health Canada's latest announcement to introduce random testing into their process to ensure the confidence of medical cannabis users across Canada" noted Denis Arsenault, Organigram CEO. "This is very much in line with the steps we've taken internally, so we are very supportive of this industry-wide initiative".


Canada: Medical Marijuana Recall Expanded After Banned Pesticide Found

Two more licensed medical marijuana producers have voluntarily recalled hundreds of grams of the drug after traces of a controversial pesticide banned in Canada were detected in their supply, raising questions about Ottawa’s oversight of an industry expected to explode with the upcoming legalization of cannabis.

Last week, Organigram, a publicly traded grower based in Moncton, expanded a Dec. 28 recall of a small amount of product to include almost all of its cannabis buds and oils produced in 2016.


Cannabis Course Planned in Canada

A college in the Atlantic Canadian province of New Brunswick plans to institute a programme on marijuana cultivation so that students can be trained to work at local companies that produce the drug, a school official says.

The French-language College Communautaire du Nouveau-Brunswick will launch the course sometime next year, said Michel Doucet, executive director of continuing education and customized learning.

Canadian Liberal Prime Minister Justin Trudeau campaigned last year on a promise to legalise recreational marijuana and the government has said it would introduce legislation by the spring of 2017.


New Brunswick bets nascent marijuana sector will bring jobs

Kevin Coft and his medical marijuana startup are benefiting in a big way as the New Brunswick government embraces the job opportunities this budding industry could bring to the province.

On Aug. 23, the government invested $4-million in Zenabis, a company Mr. Coft launched to build a proposed medical marijuana facility in Atholville, N.B. The money comes in the form of a repayable loan, and Mr. Coft says it signals that Premier Brian Gallant’s Liberal government is serious about supporting the sector.


Canada: New Brunswick Government Invests $4M in Medical Marijuana Production Facility

The government of New Brunswick is giving a proposed medical marijuana facility in the province a major financial boost — investing a total of $4 million into the operation.

The money comes from the Northern New Brunswick Economic Development Fund, through both Opportunities NB and the Regional Development Corporation who each invested $2 million.

The province says the medical marijuana project could create more than 200 full-time jobs in the northern New Brunswick town of Atholville by 2021.

“We understand how important job creation, education and health care are to New Brunswickers,” Premier Brian Gallant said in a release.


Subscribe to RSS - New Brunswick